novartis

Švicarski farmaceutski div obustavlja dio poslovanja u Rusiji

Švicarski proizvođač lijekova Novartis danas je objavio da obustavlja kapitalna ulaganja, medijsko oglašavanje i druge promotivne aktivnosti u Rusiji, ali ...

22.03.2022., 16:29

epa08972421 A Sri Lankan health worker prepares to inject a first dose of a Oxford-AstraZeneca COVID-19 vaccine shot at the Infectious Diseases Hospital (IDH) in Colombo, Sri Lanka, 29 January 2021. Sri Lankan health authorities are commencing the COVID-19 vaccination drive from the frontline workers on 29 January, after receiving 500,000 doses of the Oxford-AstraZeneca COVID-19 vaccines from neighboring India as per donation. EPA/CHAMILA KARUNARATHNE

Švicarski Novartis pomoći će u proizvodnji Pfizerova cjepiva

Švicarski proizvođač lijekova Novartis potpisao je preliminarni ugovor o osiguranju dodatnih proizvodnih kapaciteta za cjepivo Pfizera/BioNTecha kako bi se ubrzala proizvodnja cjepiva ...

29.01.2021., 14:12

epa08295338 A handout illustration made available by the Centers for Disease Control and Prevention (CDC), shows 'ultrastructural morphology' of the coronaviruses, issued 15 March 2020. The novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19). EPA/CDC HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES

Novartis polaže nade u hidroksiklorokin u borbi protiv koronavirusa

Švicarska farmaceutska tvrtka Novartis polaže naviše nade u borbi protiv koronavirusa u antimalarik hidroksiklorokin, izjavio je u nedjeljnom intervjuu za švicarske medije izvršni ...

29.03.2020., 13:12

Tag: novartis

Švicarski farmaceutski div obustavlja dio poslovanja u Rusiji

Švicarski Novartis pomoći će u proizvodnji Pfizerova cjepiva

Novartis polaže nade u hidroksiklorokin u borbi protiv koronavirusa

Aktualno

Povežite se s nama!

NACIONAL NEWS CORPORATION d.o.o. © 2024 Sva prava pridržana | Design & Development by